Rebecca Louise Jones

Dr. Rebecca Louise Jones

Institute of Education, Arts and Community, Federation University, Ballarat, Victoria, Australia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2018 in European Journal of Sport Science
Verified
Journal Article
Closed access
GAGuilherme Artioli
Guilherme Artioli
CSCraig Sale
Craig Sale
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
Carnosine was originally discovered in skeletal muscle, where it exists in larger amounts than in other tissues. The majority of research into the physiological roles of carnosine have been conducted on skeletal muscle. Given this and the potential for muscle carnosine content to be increased with supplementation, there is now a large body of research examining the ergogenic effects (or otherwise) of carnosine. More recent research, however, points towards a potential for carnosine to exert a wider range of physiological effects in other tissues, including the brain, heart, pancreas, kidney and cancer cells. Taken together, this is suggestive of a potential for carnosine to have therapeutic benefits in health and disease, although this is by no means without complication. Herein, we will provide a review of the current literature relating to the potential therapeutic effects of carnosine in health and disease.

17 August 2022 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
LPLorna Paul
Lorna Paul
MSMartijn P.M. Steultjens
Martijn P.M. Steultjens
SSStephanie Louise Smith
Stephanie Louise Smith
Lower limb muscle dysfunction is a key driver for impaired physical capacity and frailty status, both characteristics of sarcopenia. Sarcopenia is the key pathway between frailty and disability. Identifying biological markers for early diagnosis, treatment, and prevention may be key to early intervention and prevention of disability particularly mobility issues. To identify biological markers associated with lower limb muscle (dys)function in adults with sarcopenia, a systematic literature search was conducted in AMED, CINAHL, Cochrane Library, EMBASE, Medline, PubMed, Scopus, SPORTDiscus, and Web of Science databases from inception to 17 November 2021. Title, abstract, and full‐text screening, data extraction, and methodological quality assessment were performed by two reviewers independently and verified by a third reviewer. Depending on available data, associations are reported as either Pearson's correlations, regression R2 or partial R2, P value, and sample size (n). Twenty eligible studies including 3306 participants were included (females: 79%, males: 15%, unreported: 6%; mean age ranged from 53 to 92 years) with 36% in a distinct sarcopenic subgroup (females: 73%, males: 19%, unreported: 8%; mean age range 55–92 years). A total of 119 biomarkers were reported, categorized into: genetic and microRNAs (n = 64), oxidative stress (n = 10), energy metabolism (n = 18), inflammation (n = 7), enzyme (n = 4), hormone (n = 7), bone (n = 3), vitamin (n = 2), and cytokine (n = 4) markers) and seven lower limb muscle measures predominately focused on strength. Seven studies reported associations between lower limb muscle measures including (e.g. power, force, and torque) and biomarkers. In individuals with sarcopenia, muscle strength was positively associated with free testosterone (r = 0.40, P = 0.01; n = 46). In analysis with combined sarcopenic and non‐sarcopenic individuals, muscle strength was positively associated with combined genetic and methylation score (partial R2 = 0.122, P = 0.03; n = 48) and negatively associated with sarcopenia‐driven methylation score (partial R2 = 0.401, P < 0.01; n = 48). Biomarkers related to genetics (R2 = 0.001–0.014, partial R2 = 0.013–0.122, P > 0.05; n = 48), oxidative stress (r = 0.061, P > 0.05; n ≥ 77), hormone (r = 0.01, ρ = 0.052 p > 0.05, n ≥ 46) and combined protein, oxidative stress, muscle performance, and hormones (R2 = 22.0, P > 0.05; n ≥ 82) did not report significant associations with lower limb muscle strength. Several biomarkers demonstrated associations with lower limb muscle dysfunction. The current literature remains difficult to draw clear conclusions on the relationship between biomarkers and lower limb muscle dysfunction in adults with sarcopenia. Heterogeneity of biomarkers and lower limb muscle function precluded direct comparison. Use of international classification of sarcopenia and a set of core standardized outcome measures should be adopted to aid future investigation and recommendations to be made.

5 November 2024 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
SSStephanie Louise Smith
Stephanie Louise Smith
LPLorna Paul
Lorna Paul
MSMartijn P. M. Steultjens
Martijn P. M. Steultjens
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
Objectives: Skeletal muscle dysfunction is the primary cause of functional limitations in osteoarthritis, associated biomarkers have the potential as targets for early disease identification, diagnosis, and prevention of osteoarthritis disability. This review aimed to identify associations between biomarkers and lower limb skeletal muscle function in individuals with osteoarthritis. Methods: A systematic literature review and meta-analysis conducted in PubMed, MEDLINE, CINAHL, EMBASE, Scopus, SPORTDiscus and Web of Science databases from inception to 8th August 2023. Two independent reviewers performed the title, abstract, full-text screening, data extraction and methodological quality assessment. A meta-analysis was undertaken based on the available data. Results: Twenty-four studies with 4101 participants with osteoarthritis were included (females: 78%; age range; 49 to 71 years). One study reported muscle-specific biomarkers (n = 3), whilst six studies reported osteoarthritis-specific markers (n = 5). Overall, 93 biomarkers were reported, predominately characterised as inflammatory (n = 35), metabolic (n = 15), and hormones (n = 10). Muscle strength and vitamin D reported a significant association (Hedge’s g: 0.58 (Standard Error (SE): 0.27; P = 0.03), k = 3 studies). Walking speed and high-sensitivity C-reactive protein reported no significant associations (Hedge’s g: -0.02 (SE: 0.05; P = 0.73), k = 3 studies). Conclusion: Associations between biomarkers and lower limb skeletal muscle function in individuals with osteoarthritis was limited, the few studies exploring lower limb muscle measures were mainly secondary outcomes. Furthermore, biomarkers were largely related to overall health, with a lack of muscle specific biomarkers. As such, the mechanistic pathways through which these associations occur are less evident, and difficult to draw clear conclusions on these relationships. Trial registration: Registered on PROSPERO (CRD42022359405).

2 October 2022 in Journal of Sports Sciences
Verified
Journal Article
Open access
ASAbigail M Saunders
Abigail M Saunders
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
JRJoanna Richards
Joanna Richards
Variations in the haemodynamic demands of specific training modalities may explain characteristic differences in cardiac structure and function amongst athletes. However, current consensus regarding these adaptations in highly resistance-trained athletes is yet to be established. The current invetsigation aimed to collate research investigating cardiac structure and function in resistance-trained athletes, exploring the defining characteristics of Athlete’s Heart within these individuals. Seven electronic databases were searched. Studies which examined at least one measure of cardiac structure or function, included healthy, normotensive male or females (>18 years) and compared athletes engaged in a resistance training programme (>12 months) to an untrained group engaged in no structured training programme were included. Systematic selection and quality appraisal of articles was performed by two reviewers, with a random effects meta-analysis model applied to suitable studies. Studies were limited to orginal peer-reviewed articles published in English. Resistance-trained athletes (n = 949) demonstrated greater cardiac dimensions compared to their untrained counterparts (n = 1053). No clear impairments to systolic or diastolic cardiac function were observed in athletic population studied here. Resistance-trained athletes display some characteristics of the Athlete's Heart phenomenon, including greater wall thickening and chamber dilation compared to their untrained counterparts.

1 September 2025 in Journal of Physical Activity and Health
Verified
Journal Article
Closed access
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
DCDaniel L Cooper
Daniel L Cooper
JZJulia Kirstey Zakrzewski-Fruer
Julia Kirstey Zakrzewski-Fruer
DBDaniel Bailey
Daniel Bailey
Background: Older adults engage in the highest levels of sedentary behavior across all age groups. Yet, the extent to which sedentary time is associated with cardiometabolic health in older adults is unclear. This systematic review and meta-analysis examined associations between daily sedentary time and cardiometabolic biomarkers in older adults. Methods: Peer-reviewed articles which studied the association between daily sedentary time and ≥1 cardiometabolic biomarker in participants aged ≥60 years were eligible. Five electronic databases (PubMed, CINAHL, MEDLINE, Web of Science, and PsycINFO) were searched. Screening, data extraction, and study quality were undertaken independently by 2 reviewers. Meta-analyses were undertaken using random-effects models based on correlation and regression coefficients. Methodological quality was assessed using the Joanna Briggs Institute checklist. Results: Twenty-eight articles were included with sample sizes ranging from 30 to 62,754 participants. Increasing daily sedentary time was adversely associated with body mass index (Hedge g: 0.32; P = .001), waist circumference (Hedge g: 0.45; P < .001), body fat percentage (Hedge g: 0.61; P = .012), and fat mass (Hedge g: 0.30; P = .018). There were also unfavorable associations with systolic blood pressure (Hedge g: 0.37; P = .047), blood glucose (Hedge g: 0.30; P = .044), triglycerides (Hedge g: 0.36; P = .039), and high-density lipoprotein cholesterol (Hedge g: 0.34; P = .034). Conclusions: Increased daily sedentary time is adversely associated with body composition, systolic blood pressure, and blood biomarkers in older adults. Therefore, limiting sedentary behavior should be considered an important target in this population group for improved cardiometabolic health.

1 November 2021 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
PDF file
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
TSTrent Stellingwerff
Trent Stellingwerff
PSPaul Swinton
Paul Swinton
GAGuilherme Giannini Artioli
Guilherme Giannini Artioli
BSBryan Saunders
Bryan Saunders
CSCraig Sale
Craig Sale
This study determined the influence of a high- (HI) versus low-intensity (LI) cycling warm-up on blood acid-base responses and exercise capacity following ingestion of sodium bicarbonate (SB; 0.3 g/kg body mass) or a placebo (PLA; maltodextrin) 3 hr prior to warm-up. Twelve men (21 ± 2 years, 79.2 ± 3.6 kg body mass, and maximum power output [Wmax] 318 ± 36 W) completed a familiarization and four double-blind trials in a counterbalanced order: HI warm-up with SB, HI warm-up with PLA, LI warm-up with SB, and LI warm-up with PLA. LI warm-up was 15 min at 60% Wmax, while the HI warm-up (typical of elites) featured LI followed by 2 × 30 s (3-min break) at Wmax, finishing 30 min prior to a cycling capacity test at 110% Wmax. Blood bicarbonate and lactate were measured throughout. SB supplementation increased blood bicarbonate (+6.4 mmol/L; 95% confidence interval, CI [5.7, 7.1]) prior to greater reductions with HI warm-up (−3.8 mmol/L; 95% CI [−5.8, −1.8]). However, during the 30-min recovery, blood bicarbonate rebounded and increased in all conditions, with concentrations ∼5.3 mmol/L greater with SB supplementation (p < .001). Blood bicarbonate significantly declined during the cycling capacity test at 110%Wmax with greater reductions following SB supplementation (−2.4 mmol/L; 95% CI [−3.8, −0.90]). Aligned with these results, SB supplementation increased total work done during the cycling capacity test at 110% Wmax (+8.5 kJ; 95% CI [3.6, 13.4], ∼19% increase) with no significant main effect of warm-up intensity (+0.0 kJ; 95% CI [−5.0, 5.0]). Collectively, the results demonstrate that SB supplementation can improve HI cycling capacity irrespective of prior warm-up intensity, likely due to blood alkalosis.